| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1990.TB07934.X |
| P698 | PubMed publication ID | 2149050 |
| P2093 | author name string | Cony-Makhoul P | |
| Reiffers J | |||
| Texier-Maugein J | |||
| Pellegrin JL | |||
| Marit G | |||
| Brossard G | |||
| P2860 | cites work | In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients | Q35255055 |
| Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia | Q39707323 | ||
| Infection in cancer patients. A continuing association | Q39740266 | ||
| Neutropenia, fever, and infection | Q40238507 | ||
| Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia | Q40806148 | ||
| Enterococcal superinfection in patients treated with ciprofloxacin | Q43833762 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vancomycin | Q424027 |
| P304 | page(s) | 35-40 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients | |
| P478 | volume | 76 Suppl 2 |
| Q34114674 | 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer |
| Q41646436 | A closer look at vancomycin, teicoplanin, and antimicrobial resistance |
| Q39235645 | A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours |
| Q40495770 | Anti-infective treatment in intensive care: the role of glycopeptides |
| Q37392738 | Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis |
| Q77144486 | Comparative safety of teicoplanin and vancomycin |
| Q42544277 | Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design |
| Q40467559 | Pharmacokinetic Optimisation of Vancomycin Therapy |
| Q40505256 | Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials |
| Q37113420 | Teicoplanin in perspective. A critical comparison with vancomycin |
| Q24234764 | Teicoplanin versus vancomycin for proven or suspected infection |
| Q37860938 | Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential |
| Q40584161 | Use of teicoplanin in community medicine |
Search more.